182 related articles for article (PubMed ID: 16917950)
1. Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD.
Mick E; Biederman J; Spencer T; Faraone SV; Sklar P
Am J Med Genet B Neuropsychiatr Genet; 2006 Dec; 141B(8):890-4. PubMed ID: 16917950
[TBL] [Abstract][Full Text] [Related]
2. Response to methylphenidate is not influenced by DAT1 polymorphisms in a sample of Brazilian adult patients with ADHD.
Contini V; Victor MM; Marques FZ; Bertuzzi GP; Salgado CA; Silva KL; Sousa NO; Grevet EH; Belmonte-de-Abreu P; Bau CH
J Neural Transm (Vienna); 2010 Feb; 117(2):269-76. PubMed ID: 20049490
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder.
Roman T; Rohde LA; Hutz MH
Am J Pharmacogenomics; 2004; 4(2):83-92. PubMed ID: 15059031
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.
Kambeitz J; Romanos M; Ettinger U
Pharmacogenomics J; 2014 Feb; 14(1):77-84. PubMed ID: 23588108
[TBL] [Abstract][Full Text] [Related]
5. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH
Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
[TBL] [Abstract][Full Text] [Related]
6. Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).
Kooij JS; Boonstra AM; Vermeulen SH; Heister AG; Burger H; Buitelaar JK; Franke B
Am J Med Genet B Neuropsychiatr Genet; 2008 Mar; 147B(2):201-8. PubMed ID: 17955457
[TBL] [Abstract][Full Text] [Related]
7. Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.
Gruber R; Joober R; Grizenko N; Leventhal BL; Cook EH; Stein MA
J Child Adolesc Psychopharmacol; 2009 Jun; 19(3):233-9. PubMed ID: 19519258
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review.
Contini V; Rovaris DL; Victor MM; Grevet EH; Rohde LA; Bau CH
Eur Neuropsychopharmacol; 2013 Jun; 23(6):555-60. PubMed ID: 22709890
[TBL] [Abstract][Full Text] [Related]
9. Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children.
Kereszturi E; Tarnok Z; Bognar E; Lakatos K; Farkas L; Gadoros J; Sasvari-Szekely M; Nemoda Z
Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1431-5. PubMed ID: 18214865
[TBL] [Abstract][Full Text] [Related]
10. Genetic imaging study with [Tc-
Akay AP; Kaya GÇ; Kose S; Yazıcıoğlu ÇE; Erkuran HÖ; Güney SA; Oğuz K; Keskin D; Baykara B; Emiroğlu Nİ; Eren MŞ; Kızıldağ S; Ertay T; Özsoylu D; Miral S; Durak H; Gönül AS; Rohde LA
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():294-300. PubMed ID: 29684537
[TBL] [Abstract][Full Text] [Related]
11. Molecular imaging genetics of methylphenidate response in ADHD and substance use comorbidity.
Szobot CM; Roman T; Hutz MH; Genro JP; Shih MC; Hoexter MQ; Júnior N; Pechansky F; Bressan RA; Rohde LA
Synapse; 2011 Feb; 65(2):154-9. PubMed ID: 20593420
[TBL] [Abstract][Full Text] [Related]
12. Association of dopamine, serotonin, and nicotinic gene polymorphisms with methylphenidate response in ADHD.
Tharoor H; Lobos EA; Todd RD; Reiersen AM
Am J Med Genet B Neuropsychiatr Genet; 2008 Jun; 147B(4):527-30. PubMed ID: 17948872
[TBL] [Abstract][Full Text] [Related]
13. Evidence of an association between 10/10 genotype of DAT1 and endophenotypes of attention deficit/hyperactivity disorder.
Agudelo JA; Gálvez JM; Fonseca DJ; Mateus HE; Talero-Gutiérrez C; Velez-Van-Meerbeke A
Neurologia; 2015 Apr; 30(3):137-43. PubMed ID: 24461309
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the DAT1 gene and the effects of methylphenidate administration in adult attention deficit hyperactivity disorder: a magnetic resonance spectroscopy study.
Inci Kenar AN; Ünal GA; Güler H; Albuz B; Kıroğlu Y; Erdal ME; Herken H
Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1373-8. PubMed ID: 27097961
[TBL] [Abstract][Full Text] [Related]
15. A 40-bp VNTR polymorphism in the 3'-untranslated region of DAT1/SLC6A3 is associated with ADHD but not with alcoholism.
Šerý O; Paclt I; Drtílková I; Theiner P; Kopečková M; Zvolský P; Balcar VJ
Behav Brain Funct; 2015 Jun; 11():21. PubMed ID: 26058807
[TBL] [Abstract][Full Text] [Related]
16. The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density.
VanNess SH; Owens MJ; Kilts CD
BMC Genet; 2005 Nov; 6():55. PubMed ID: 16309561
[TBL] [Abstract][Full Text] [Related]
17. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder.
Barr CL; Xu C; Kroft J; Feng Y; Wigg K; Zai G; Tannock R; Schachar R; Malone M; Roberts W; Nöthen MM; Grünhage F; Vandenbergh DJ; Uhl G; Sunohara G; King N; Kennedy JL
Biol Psychiatry; 2001 Feb; 49(4):333-9. PubMed ID: 11239904
[TBL] [Abstract][Full Text] [Related]
18. Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics.
Polanczyk G; Zeni C; Genro JP; Roman T; Hutz MH; Rohde LA
Pharmacogenomics; 2005 Apr; 6(3):225-34. PubMed ID: 16013954
[TBL] [Abstract][Full Text] [Related]
19. [Association studies of dopamine D4 receptor gene and dopamine transporter gene polymorphisms in Han Chinese patients with attention deficit hyperactivity disorder].
Qian Q; Wang Y; Li J; Yang L; Wang B; Zhou R
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 35(4):412-8. PubMed ID: 12947560
[TBL] [Abstract][Full Text] [Related]
20. Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1 and ADHD: findings from a sample of adults.
de Azeredo LA; Rovaris DL; Mota NR; Polina ER; Marques FZ; Contini V; Vitola ES; Belmonte-de-Abreu P; Rohde LA; Grevet EH; Bau CH
Eur Arch Psychiatry Clin Neurosci; 2014 Aug; 264(5):401-8. PubMed ID: 24487615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
